Mixed Q1 Results for Plexus, Watsco, AT&T, Wabtec

First quarter earnings from several major companies showed mixed reactions amid sector-specific challenges. Plexus met revenue expectations, driven by strong new program wins in engineering and healthcare, but faced a muted response due to a cautious outlook. Chemed modestly exceeded expectations, with robust hospice performance, but faced concerns over Medicare cap management and temporary cash flow timing. Watsco encountered operational challenges from the industry shift to A2L refrigerants, impacting its performance despite some margin improvement. AT&T experienced a positive market reaction with growth in mobility and fiber subscribers, while Wabtec benefited from international expansion and cost controls that supported margin growth. Overall, analyst focus remained on tariffs, cost management, and navigating sector headwinds.